Mediators of Inflammation · 2014 · 73 citations · 34 references
MedicineOncologyPharmacologyInflammationMetastasisMolecular OncologyCancer Cell SignalingCytokine Receptor SignalingMetastatic Breast CancerAnticancer ActivityBreast Cancer ProgressionCancer Cell Proliferation InhibitionCytokine Signaling In CancerInterleukin-6 InhibitionMetastatic Breast Cancer BiologyMetastatic Breast Cancer TreatmentStat3 Signaling
Cancer inflammation promotes cancer progression, resulting in a high risk of cancer. Here, we demonstrate that our new herbal extract, SH003, suppresses both tumor growth and metastasis of MDA-MB-231 breast cancer cells via inhibiting STAT3-IL-6 signaling path. Our new herbal formula, SH003, mixed extract from Astragalus membranaceus, Angelica gigas, and Trichosanthes kirilowii Maximowicz, suppressed MDA-MB-231 tumor growth and lung metastasis in vivo and reduced the viability and metastatic abilities of MDA-MB-231 cells in vitro. Furthermore, SH003 inhibited STAT3 activation, which resulted in a reduction of IL-6 production. Therefore, we conclude that SH003 suppresses highly metastatic breast cancer growth and metastasis by inhibiting STAT3-IL-6 signaling path.
34
Comprehensive molecular portraits of human breast tumours
Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence
Rebecca Dent, Maureen Trudeau, Kathleen I. Pritchard et al. · Clinical Cancer Research · 2007 · 5.1K citations · Full text
Circulating interleukin‐6 predicts survival in patients with metastatic breast cancer
Roberto Salgado, Sara Junius, Ina Benoy et al. · International Journal of Cancer · 2002 · 436 citations · Full text
Medicine, Immunology, Oncology +14
Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer.
Fanghua Qi, Anyuan Li, Yoshinori Inagaki et al. · PubMed · 2010 · 347 citations
Medicine, Oncology, Pharmacology +17